Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 70.25

+0.1%

Nov 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who started this subject	8/28/2003 8:18:30 PM
From: JMarcus	Read Replies (1) of 3722

NTII held up pretty well after reaching resistance at the $5.00 level (today's high). Closed at $4.95. The stock has been on a tear these past five days. finance.yahoo.com Upcoming milestones: Memantine for Alzheimer's disease is moving forward to an FDA Advisory Panel Meeting on September 24, 2003. A Prescription Drug User Fee Act (PDUFA) response is due in October 2003h. Two pivotal Phase III trials of XERECEPT(TM) will be initiated in November. If the stock can close above $5.00 tomorrow, it looks like pretty clear sailing up to $6.00. Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next